Prelude Therapeutics Inc (PRLD)
4.01
-0.03
(-0.74%)
USD |
NASDAQ |
Apr 26, 16:00
4.01
0.00 (0.00%)
After-Hours: 20:00
Prelude Therapeutics Price: 4.01 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 3.99 | 4.09 | 3.99 | 4.04 | 115098.0 |
Apr 24, 2024 | 3.87 | 4.13 | 3.87 | 3.87 | 28584.00 |
Apr 23, 2024 | 3.89 | 4.07 | 3.87 | 3.87 | 24900.00 |
Apr 22, 2024 | 3.75 | 3.964 | 3.75 | 3.85 | 50051.00 |
Apr 19, 2024 | 3.45 | 3.86 | 3.45 | 3.72 | 57910.00 |
Apr 18, 2024 | 4.16 | 4.18 | 3.42 | 3.44 | 112889.0 |
Apr 17, 2024 | 4.80 | 4.98 | 4.10 | 4.18 | 68937.00 |
Apr 16, 2024 | 5.63 | 5.63 | 4.79 | 4.91 | 38381.00 |
Apr 15, 2024 | 5.75 | 5.83 | 5.416 | 5.63 | 89987.00 |
Apr 12, 2024 | 5.27 | 5.77 | 5.12 | 5.62 | 58031.00 |
Apr 11, 2024 | 4.94 | 5.35 | 4.855 | 5.22 | 45170.00 |
Apr 10, 2024 | 4.82 | 5.17 | 4.67 | 4.95 | 24121.00 |
Apr 09, 2024 | 4.69 | 5.07 | 4.56 | 4.99 | 64215.00 |
Apr 08, 2024 | 4.72 | 4.82 | 4.60 | 4.70 | 15589.00 |
Apr 05, 2024 | 4.67 | 4.98 | 4.47 | 4.70 | 17673.00 |
Apr 04, 2024 | 4.72 | 4.85 | 4.58 | 4.74 | 21812.00 |
Apr 03, 2024 | 4.52 | 4.755 | 4.52 | 4.72 | 28329.00 |
Apr 02, 2024 | 4.63 | 4.65 | 4.41 | 4.62 | 31908.00 |
Apr 01, 2024 | 4.76 | 4.93 | 4.610 | 4.69 | 14441.00 |
Mar 28, 2024 | 4.80 | 4.995 | 4.72 | 4.74 | 32074.00 |
Mar 27, 2024 | 4.68 | 4.92 | 4.56 | 4.77 | 33947.00 |
Mar 26, 2024 | 4.56 | 4.82 | 4.49 | 4.61 | 27359.00 |
Mar 25, 2024 | 4.67 | 4.923 | 4.53 | 4.61 | 35697.00 |
Mar 22, 2024 | 4.83 | 4.90 | 4.636 | 4.70 | 28969.00 |
Mar 21, 2024 | 4.93 | 4.975 | 4.750 | 4.82 | 28586.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.69
Minimum
Oct 31 2023
91.68
Maximum
Feb 10 2021
17.65
Average
6.815
Median
Price Benchmarks
CEL-SCI Corp | 1.43 |
AIM ImmunoTech Inc | 0.424 |
IGC Pharma Inc | 0.447 |
NovaBay Pharmaceuticals Inc | 0.0781 |
Protalix BioTherapeutics Inc | 1.15 |
Price Related Metrics
Price to Book Value | 0.9289 |
Earnings Yield | -50.87% |
Market Cap | 220.23M |